Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution.
Keipert
P E
PE
Alliance Pharmaceutical Corp., San Diego, CA.
Faithfull
N S
NS
Bradley
J D
JD
Hazard
D Y
DY
Hogan
J
J
Levisetti
M S
MS
Peters
R M
RM
D000818:Animals; D001802:Blood Substitutes / Q000008:administration & dosage*; D001804:Blood Transfusion, Autologous; D001809:Blood Viscosity / Q000187:drug effects; D001810:Blood Volume; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004655:Emulsions; D005466:Fluorocarbons / Q000008:administration & dosage*; D006400:Hematocrit; D006438:Hemodilution; D006842:Hydrocarbons, Brominated; D007262:Infusions, Intravenous; D007430:Intraoperative Care; D010100:Oxygen / Q000097:blood*; D010101:Oxygen Consumption / Q000187:drug effects
D001802:Blood Substitutes; D004655:Emulsions; D005466:Fluorocarbons; D006842:Hydrocarbons, Brominated; C003072:perflubron; D010100:Oxygen